Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vaccine Effectiveness × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2292 Neoplasms 1669 Prostatic Neoplasms 1188 Lung Neoplasms 877 Carcinoma, Non-Small-Cell Lung 839 Colorectal Neoplasms 834 Leukemia, Myeloid, Acute 592 Pancreatic Neoplasms 571 Multiple Myeloma 530 Carcinoma, Hepatocellular 505 Brain Neoplasms 491 Neoplasm Metastasis 467 Head and Neck Neoplasms 444 Melanoma 407 Ovarian Neoplasms 406 Precursor Cell Lymphoblastic Leukemia-Lymphoma 402 Glioblastoma 376 Stomach Neoplasms 373 Squamous Cell Carcinoma of Head and Neck 361 Uterine Cervical Neoplasms 346 Recurrence 338 Colonic Neoplasms 330 Hematologic Neoplasms 329 Sarcoma 318 Rectal Neoplasms 315 Lymphoma 315 Triple Negative Breast Neoplasms 289 Carcinoma, Renal Cell 285 Urinary Bladder Neoplasms 272 Glioma 272

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡